Filing Details
- Accession Number:
- 0001437749-16-043049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-07 17:11:21
- Reporting Period:
- 2016-12-05
- Filing Date:
- 2016-12-07
- Accepted Time:
- 2016-12-07 17:11:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1586049 | Oxford Immunotec Global Plc | OXFD | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1592286 | Peter Wrighton-Smith | C/O Oxford Immunotec Global Plc 94C Innovation Drive Abingdon, Oxfordshire X0 OX14 4RZ | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2016-12-05 | 1,140 | $0.81 | 444,454 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2016-12-05 | 1,140 | $15.00 | 443,314 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2016-12-05 | 1,140 | $0.00 | 1,140 | $0.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 108,490 | 2020-02-17 | No | 4 | M | Direct |
Footnotes
- The original exercise price of these options was priced in GBP at GBP0.51 and converted to US$ at an exchange rate of US$1.58823=1GBP.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2015, as amended.
- Exercise from an option granted February 28, 2013, which became fully vested on April 1, 2014.
Billionaire Hedge Funds
